Talmadge E. King Jr, MD

Photo of Talmadge E. King Jr, MD
Title(s)Professor, Medicine
SchoolSchool of Medicine
Address513 Parnassus Avenue MSB, #224B
San Francisco CA 94143
vCardDownload vCard
    Other Positions
    Title(s)Dean Emeritus, UCSF School of Medicine


    Collapse Overview 
    Collapse overview
    Dr. Talmadge E. King, Jr. was named dean of the UCSF School of Medicine and vice chancellor for medical affairs in May of 2015. He began his career at UCSF in 1997 as chief of Medical Services at Priscilla Chan and Mark Zuckerberg San Francisco General Hospital and Trauma Center. From 2006 to 2015, he served as chair of the UCSF Department of Medicine, the largest department in the school, with approximately 29 percent of the school's full-time faculty.

    A physician-scientist, King’s research has focused on inflammatory and immunologic lung injury. He is best known for his pioneering work in the management of the interstitial pneumonias, a scarring process that often leads to death. His bibliography comprises more than 300 publications and he has co-edited eight books, including the acclaimed reference book, "Interstitial Lung Disease," now in its fifth edition.

    King graduated from Gustavus Adolphus College and earned his medical degree at Harvard Medical School, followed by a residency at Emory University Affiliated Hospitals in Atlanta, Ga. and a pulmonary fellowship at the University of Colorado Health Sciences Center in Denver.

    He is a member of the Institute of Medicine of the National Academy of Sciences, American Academy of Arts and Sciences, Association of American Physicians, American Clinical and Climatological Association and the Fleischner Society. He is a master of the American College of Physicians and fellow of the American College of Chest Physicians. He won the 2007 Trudeau Medal, the highest honor of the American Thoracic Society.

    Collapse Biography 
    Collapse education and training
    University of Colorado Medical CenteFellowship1979Pulmonary/Critical Care
    Emory UniversityResidency1977Internal Medicine
    Harvard UniversityM.D.1974School of Medicine
    University of California, San Francisco, CA2018Diversity, Equity, and Inclusion Champion Training
    Collapse awards and honors
    Association of Professors of Medicine (APM)20162016 APM Robert H. Williams, MD, Distinguished Chair of Medicine Award
    Foundation of the American Thoracic Society 2012Breathing for Life Award
    Gustavus Adolphus College2012Sesquicentennial Award
    American Academy of Arts and Sciences2011 Fellow
    American College of Physicians 2010Master
    Gustavus Alumni Association, Gustavus Adolphus College2008Alumni Citation
    American Thoracic Society2007Trudeau Medal
    Institute of Medicine, National Academy of Sciences2004Member
    Public Advisory Roundtable of the American Thoracic Society2003PAR Excellence Award
    Association of American Physicians1998Member
    California Thoracic Society1998Elected honorary member
    Colorado Thoracic Society, American Lung Association of Colorado1998Member. Colorado Pulmonary Hall of Fame
    The Fleischner Society 1997Member
    Western Association of Physicians 1993Member
    American Lung Association of Colorado1992James J. Waring Award For Outstanding Leadership in the Treatment of Lung Disease
    American College of Physicians 1986Fellow
    American College of Chest Physicians1984Fellow
    Alumni Association, Gustavus Adolphus College1980First Decade Award for Early Achievement
    Gustavus Adolphus College1970Guild of St. Ansger Honor Society

    Collapse Research 
    Collapse research activities and funding
    Idiopathic Pulmonary Fibrosis Clinical Research Network
    NIH U10HL080685May 1, 2005 - Apr 30, 2012
    Role: Principal Investigator
    IMMUNOLOGIC REGULATION OF PULMONARY FIBROSIS
    NIH P50HL056556Dec 1, 1996 - Jan 31, 2002
    Role: Co-Investigator
    General Clinical Research Center
    NIH M01RR000051Dec 1, 1978 - Mar 31, 2010
    Role: Co-Investigator
    Collapse Clinical Trials

    Collapse Featured Content 
    Collapse Featured Videos
    Collapse Academic Senate

    Collapse Bibliographic 
    Collapse publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Cryptogenic Organizing Pneumonia. N Engl J Med. 2022 Mar 17; 386(11):1058-1069. King TE, Lee JS. PMID: 35294814.
      View in: PubMed   Mentions: 55     Fields:    Translation:Humans
    2. E-Cigarette or Vaping Product Use-associated Lung Injury: Developing a Research Agenda. An NIH Workshop Report. Am J Respir Crit Care Med. 2020 09 15; 202(6):795-802. Crotty Alexander LE, Ware LB, Calfee CS, Callahan SJ, Eissenberg T, Farver C, Goniewicz ML, Jaspers I, Kheradmand F, King TE, Meyer NJ, Mikheev VB, Shields PG, Shihadeh A, Strongin R, Tarran R. PMID: 32243764; PMCID: PMC7491408.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    3. How Small Differences in Assessed Clinical Performance Amplify to Large Differences in Grades and Awards: A Cascade With Serious Consequences for Students Underrepresented in Medicine. Acad Med. 2018 09; 93(9):1286-1292. Teherani A, Hauer KE, Fernandez A, King TE, Lucey C. PMID: 29923892.
      View in: PubMed   Mentions: 94     Fields:    Translation:Humans
    4. Lessons From an Educational Never Event. JAMA Intern Med. 2017 10 01; 177(10):1415-1416. Lucey CR, Navarro R, King TE. PMID: 28846754.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    5. Mortality Risk Prediction in Scleroderma-Related Interstitial Lung Disease: The SADL Model. Chest. 2017 11; 152(5):999-1007. Morisset J, Vittinghoff E, Elicker BM, Hu X, Le S, Ryu JH, Jones KD, Haemel A, Golden JA, Boin F, Ley B, Wolters PJ, King TE, Collard HR, Lee JS. PMID: 28629914; PMCID: PMC5812750.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    6. The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung disease. Respir Med. 2017 06; 127:51-56. Morisset J, Vittinghoff E, Lee BY, Tonelli R, Hu X, Elicker BM, Ryu JH, Jones KD, Cerri S, Manfredi A, Sebastiani M, Gross AJ, Ley B, Wolters PJ, King TE, Kim DS, Collard HR, Lee JS. PMID: 28502419; PMCID: PMC5506836.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    7. The use of pretest probability increases the value of high-resolution CT in diagnosing usual interstitial pneumonia. Thorax. 2017 May; 72(5):424-429. Brownell R, Moua T, Henry TS, Elicker BM, White D, Vittinghoff E, Jones KD, Urisman A, Aravena C, Johannson KA, Golden JA, King TE, Wolters PJ, Collard HR, Ley B. PMID: 28082530; PMCID: PMC5555580.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    8. Early Experiences After Adopting a Quality Improvement Portfolio Into the Academic Advancement Process. Acad Med. 2017 01; 92(1):78-82. Sehgal NL, Neeman N, King TE. PMID: 27119329.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    9. A diagnostic model for chronic hypersensitivity pneumonitis. Thorax. 2016 10; 71(10):951-4. Johannson KA, Elicker BM, Vittinghoff E, Assayag D, de Boer K, Golden JA, Jones KD, King TE, Koth LL, Lee JS, Ley B, Wolters PJ, Collard HR. PMID: 27245779; PMCID: PMC5530732.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    10. Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosis. Thorax. 2016 05; 71(5):429-35. Nathan SD, Albera C, Bradford WZ, Costabel U, du Bois RM, Fagan EA, Fishman RS, Glaspole I, Glassberg MK, Glasscock KF, King TE, Lancaster L, Lederer DJ, Lin Z, Pereira CA, Swigris JJ, Valeyre D, Noble PW, Wells AU. PMID: 26968970; PMCID: PMC4862066.
      View in: PubMed   Mentions: 78     Fields:    Translation:HumansCTClinical Trials
    11. Safety of pirfenidone in patients with idiopathic pulmonary fibrosis: integrated analysis of cumulative data from 5 clinical trials. BMJ Open Respir Res. 2016; 3(1):e000105. Lancaster L, Albera C, Bradford WZ, Costabel U, du Bois RM, Fagan EA, Fishman RS, Glaspole I, Glassberg MK, King TE, Lederer DJ, Lin Z, Nathan SD, Pereira CA, Swigris JJ, Valeyre D, Noble PW. PMID: 26835133; PMCID: PMC4716177.
      View in: PubMed   Mentions: 56  
    12. Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials. Eur Respir J. 2016 Jan; 47(1):243-53. Noble PW, Albera C, Bradford WZ, Costabel U, du Bois RM, Fagan EA, Fishman RS, Glaspole I, Glassberg MK, Lancaster L, Lederer DJ, Leff JA, Nathan SD, Pereira CA, Swigris JJ, Valeyre D, King TE. PMID: 26647432; PMCID: PMC4697914.
      View in: PubMed   Mentions: 204     Fields:    Translation:Humans
    13. American Thoracic Society-European Respiratory Society Classification of the Idiopathic Interstitial Pneumonias: Advances in Knowledge since 2002. Radiographics. 2015 Nov-Dec; 35(7):1849-71. Sverzellati N, Lynch DA, Hansell DM, Johkoh T, King TE, Travis WD. PMID: 26452110.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    14. Survival in interstitial pneumonia with features of autoimmune disease: a comparison of proposed criteria. Respir Med. 2015 Oct; 109(10):1326-31. Assayag D, Kim EJ, Elicker BM, Jones KD, Golden JA, King TE, Koth LL, Shum AK, Wolters PJ, Collard HR, Lee JS. PMID: 26303338.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    15. Sensitivity Analyses of the Change in FVC in a Phase 3 Trial of Pirfenidone for Idiopathic Pulmonary Fibrosis. Chest. 2015 Jul; 148(1):196-201. Lederer DJ, Bradford WZ, Fagan EA, Glaspole I, Glassberg MK, Glasscock KF, Kardatzke D, King TE, Lancaster LH, Nathan SD, Pereira CA, Sahn SA, Swigris JJ, Noble PW. PMID: 25856121; PMCID: PMC4493875.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    16. The effect of bronchodilators on forced vital capacity measurement in patients with idiopathic pulmonary fibrosis. Respir Med. 2015 Aug; 109(8):1058-62. Assayag D, Vittinghoff E, Ryerson CJ, Cocconcelli E, Tonelli R, Hu X, Elicker BM, Golden JA, Jones KD, King TE, Koth LL, Lee JS, Ley B, Shum AK, Wolters PJ, Ryu JH, Collard HR. PMID: 26140806; PMCID: PMC4522344.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    17. CT staging and monitoring of fibrotic interstitial lung diseases in clinical practice and treatment trials: a position paper from the Fleischner Society. Lancet Respir Med. 2015 Jun; 3(6):483-96. Hansell DM, Goldin JG, King TE, Lynch DA, Richeldi L, Wells AU. PMID: 25975761.
      View in: PubMed   Mentions: 88     Fields:    Translation:Humans
    18. Validation of test performance characteristics and minimal clinically important difference of the 6-minute walk test in patients with idiopathic pulmonary fibrosis. Respir Med. 2015 Jul; 109(7):914-22. Nathan SD, du Bois RM, Albera C, Bradford WZ, Costabel U, Kartashov A, Noble PW, Sahn SA, Valeyre D, Weycker D, King TE. PMID: 25956020.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansCTClinical Trials
    19. A new era in idiopathic pulmonary fibrosis: considerations for future clinical trials. Eur Respir J. 2015 Jul; 46(1):243-9. Collard HR, Bradford WZ, Cottin V, Flaherty KR, King TE, Koch GG, Kolb M, Martinez FJ, Montgomery B, Raghu G, Richeldi L, Rose D, Wells AU, Brown KK. PMID: 25900377.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    20. Association of hospital admission and forced vital capacity endpoints with survival in patients with idiopathic pulmonary fibrosis: analysis of a pooled cohort from three clinical trials. Lancet Respir Med. 2015 May; 3(5):388-96. Durheim MT, Collard HR, Roberts RS, Brown KK, Flaherty KR, King TE, Palmer SM, Raghu G, Snyder LD, Anstrom KJ, Martinez FJ, IPFnet investigators. PMID: 25890798; PMCID: PMC4760351.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    21. Do all patients with idiopathic pulmonary fibrosis warrant a trial of therapeutic intervention? A pro-con perspective. Respirology. 2015 Apr; 20(3):389-94. Moodley Y, Corte T, Richeldi L, King TE. PMID: 25727967.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    22. Analysis of lung function and survival in RECAP: An open-label extension study of pirfenidone in patients with idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis. 2014 Oct 20; 31(3):198-205. Costabel U, Albera C, Bradford WZ, Hormel P, King TE, Noble PW, Sahn SA, Valeyre D, du Bois RM. PMID: 25363219.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCTClinical Trials
    23. Treatments for idiopathic pulmonary fibrosis. N Engl J Med. 2014 08 21; 371(8):783-4. King TE, Noble PW, Bradford WZ. PMID: 25147884.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    24. Smoking-related idiopathic interstitial pneumonia. Eur Respir J. 2014 Sep; 44(3):594-602. Flaherty KR, Fell C, Aubry MC, Brown K, Colby T, Costabel U, Franks TJ, Gross BH, Hansell DM, Kazerooni E, Kim DS, King TE, Kitachi M, Lynch D, Myers J, Nagai S, Nicholson AG, Poletti V, Raghu G, Selman M, Toews G, Travis W, Wells AU, Vassallo R, Martinez FJ. PMID: 25063244; PMCID: PMC4366053.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansPHPublic Health
    25. Idiopathic pulmonary fibrosis: CT and risk of death. Radiology. 2014 Nov; 273(2):570-9. Ley B, Elicker BM, Hartman TE, Ryerson CJ, Vittinghoff E, Ryu JH, Lee JS, Jones KD, Richeldi L, King TE, Collard HR. PMID: 24927326; PMCID: PMC4334234.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    26. Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med. 2014 May 29; 370(22):2093-101. Idiopathic Pulmonary Fibrosis Clinical Research Network, Martinez FJ, de Andrade JA, Anstrom KJ, King TE, Raghu G. PMID: 24836309; PMCID: PMC4116664.
      View in: PubMed   Mentions: 198     Fields:    Translation:Humans
    27. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2014 May 29; 370(22):2083-92. King TE, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, Gorina E, Hopkins PM, Kardatzke D, Lancaster L, Lederer DJ, Nathan SD, Pereira CA, Sahn SA, Sussman R, Swigris JJ, Noble PW, ASCEND Study Group. PMID: 24836312.
      View in: PubMed   Mentions: 1807     Fields:    Translation:HumansCTClinical Trials
    28. Comprehensive assessment of the long-term safety of pirfenidone in patients with idiopathic pulmonary fibrosis. Respirology. 2014 Jul; 19(5):740-7. Valeyre D, Albera C, Bradford WZ, Costabel U, King TE, Leff JA, Noble PW, Sahn SA, du Bois RM. PMID: 24836849; PMCID: PMC4230393.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    29. All-cause mortality rate in patients with idiopathic pulmonary fibrosis. Implications for the design and execution of clinical trials. Am J Respir Crit Care Med. 2014 Apr 01; 189(7):825-31. King TE, Albera C, Bradford WZ, Costabel U, du Bois RM, Leff JA, Nathan SD, Sahn SA, Valeyre D, Noble PW. PMID: 24476390.
      View in: PubMed   Mentions: 74     Fields:    Translation:Humans
    30. Predicting survival across chronic interstitial lung disease: the ILD-GAP model. Chest. 2014 Apr; 145(4):723-728. Ryerson CJ, Vittinghoff E, Ley B, Lee JS, Mooney JJ, Jones KD, Elicker BM, Wolters PJ, Koth LL, King TE, Collard HR. PMID: 24114524.
      View in: PubMed   Mentions: 245     Fields:    Translation:Humans
    31. Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report. Am J Respir Crit Care Med. 2014 Jan 15; 189(2):214-22. Blackwell TS, Tager AM, Borok Z, Moore BB, Schwartz DA, Anstrom KJ, Bar-Joseph Z, Bitterman P, Blackburn MR, Bradford W, Brown KK, Chapman HA, Collard HR, Cosgrove GP, Deterding R, Doyle R, Flaherty KR, Garcia CK, Hagood JS, Henke CA, Herzog E, Hogaboam CM, Horowitz JC, King TE, Loyd JE, Lawson WE, Marsh CB, Noble PW, Noth I, Sheppard D, Olsson J, Ortiz LA, O'Riordan TG, Oury TD, Raghu G, Roman J, Sime PJ, Sisson TH, Tschumperlin D, Violette SM, Weaver TE, Wells RG, White ES, Kaminski N, Martinez FJ, Wynn TA, Thannickal VJ, Eu JP. PMID: 24160862; PMCID: PMC3983890.
      View in: PubMed   Mentions: 151     Fields:    Translation:HumansAnimalsCells
    32. Rheumatoid arthritis associated interstitial lung disease: a review. Medicina (B Aires). 2014; 74(2):158-65. Assayag D, Lee JS, King TE. PMID: 24736263.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    33. Predictors of mortality in rheumatoid arthritis-related interstitial lung disease. Respirology. 2014 May; 19(4):493-500. Assayag D, Lubin M, Lee JS, King TE, Collard HR, Ryerson CJ. PMID: 24372981.
      View in: PubMed   Mentions: 83     Fields:    Translation:Humans
    34. Assessing exertional dyspnea in patients with idiopathic pulmonary fibrosis. Respir Med. 2014 Jan; 108(1):181-8. Swigris JJ, Streiner DL, Brown KK, Belkin A, Green KE, Wamboldt FS, IPFnet Investigators. PMID: 24388667; PMCID: PMC3951298.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    35. 6-Minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosis. Eur Respir J. 2014 May; 43(5):1421-9. du Bois RM, Albera C, Bradford WZ, Costabel U, Leff JA, Noble PW, Sahn SA, Valeyre D, Weycker D, King TE. PMID: 24311766.
      View in: PubMed   Mentions: 113     Fields:    Translation:HumansCTClinical Trials
    36. Rheumatoid arthritis-associated interstitial lung disease: radiologic identification of usual interstitial pneumonia pattern. Radiology. 2014 Feb; 270(2):583-8. Assayag D, Elicker BM, Urbania TH, Colby TV, Kang BH, Ryu JH, King TE, Collard HR, Kim DS, Lee JS. PMID: 24126367; PMCID: PMC4228744.
      View in: PubMed   Mentions: 54     Fields:    Translation:Humans
    37. An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013 Sep 15; 188(6):733-48. Travis WD, Costabel U, Hansell DM, King TE, Lynch DA, Nicholson AG, Ryerson CJ, Ryu JH, Selman M, Wells AU, Behr J, Bouros D, Brown KK, Colby TV, Collard HR, Cordeiro CR, Cottin V, Crestani B, Drent M, Dudden RF, Egan J, Flaherty K, Hogaboam C, Inoue Y, Johkoh T, Kim DS, Kitaichi M, Loyd J, Martinez FJ, Myers J, Protzko S, Raghu G, Richeldi L, Sverzellati N, Swigris J, Valeyre D, ATS/ERS Committee on Idiopathic Interstitial Pneumonias. PMID: 24032382; PMCID: PMC5803655.
      View in: PubMed   Mentions: 1852     Fields:    Translation:Humans
    38. Radiographic fibrosis score predicts survival in hypersensitivity pneumonitis. Chest. 2013 Aug; 144(2):586-592. Mooney JJ, Elicker BM, Urbania TH, Agarwal MR, Ryerson CJ, Nguyen MLT, Woodruff PG, Jones KD, Collard HR, King TE, Koth LL. PMID: 23392130.
      View in: PubMed   Mentions: 69     Fields:    Translation:Humans
    39. Suspected acute exacerbation of idiopathic pulmonary fibrosis as an outcome measure in clinical trials. Respir Res. 2013 Jul 13; 14:73. Collard HR, Yow E, Richeldi L, Anstrom KJ, Glazer C, IPFnet investigators. PMID: 23848435; PMCID: PMC3729659.
      View in: PubMed   Mentions: 89     Fields:    Translation:Humans
    40. Clinical features and outcomes in combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis. Chest. 2013 Jul; 144(1):234-240. Ryerson CJ, Hartman T, Elicker BM, Ley B, Lee JS, Abbritti M, Jones KD, King TE, Ryu J, Collard HR. PMID: 23370641.
      View in: PubMed   Mentions: 113     Fields:    Translation:Humans
    41. Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials. Lancet Respir Med. 2013 Jul; 1(5):369-76. Lee JS, Collard HR, Anstrom KJ, Martinez FJ, Noth I, Roberts RS, Yow E, Raghu G, IPFnet Investigators. PMID: 24429201; PMCID: PMC4059609.
      View in: PubMed   Mentions: 142     Fields:    Translation:Humans
    42. Reply: idiopathic pulmonary fibrosis: perspectives on clinically meaningful primary endpoints in phase 3 clinical trials. Am J Respir Crit Care Med. 2013 Jun 01; 187(11):1272. Raghu G, Collard HR, Anstrom KJ, Flaherty KR, Fleming TR, King TE, Martinez FJ, Brown KK. PMID: 23725623.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    43. Sildenafil preserves exercise capacity in patients with idiopathic pulmonary fibrosis and right-sided ventricular dysfunction. Chest. 2013 Jun; 143(6):1699-1708. Han MK, Bach DS, Hagan PG, Yow E, Flaherty KR, Toews GB, Anstrom KJ, Martinez FJ, IPFnet Investigators. PMID: 23732584; PMCID: PMC3673665.
      View in: PubMed   Mentions: 79     Fields:    Translation:Humans
    44. Prevalence and prognosis of unclassifiable interstitial lung disease. Eur Respir J. 2013 Sep; 42(3):750-7. Ryerson CJ, Urbania TH, Richeldi L, Mooney JJ, Lee JS, Jones KD, Elicker BM, Koth LL, King TE, Wolters PJ, Collard HR. PMID: 23222877.
      View in: PubMed   Mentions: 121     Fields:    Translation:Humans
    45. Prevalence and clinical significance of circulating autoantibodies in idiopathic pulmonary fibrosis. Respir Med. 2013 Feb; 107(2):249-55. Lee JS, Kim EJ, Lynch KL, Elicker B, Ryerson CJ, Katsumoto TR, Shum AK, Wolters PJ, Cerri S, Richeldi L, Jones KD, King TE, Collard HR. PMID: 23186614; PMCID: PMC3543473.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    46. Hypersensitivity pneumonitis: insights in diagnosis and pathobiology. Am J Respir Crit Care Med. 2012 Aug 15; 186(4):314-24. Selman M, Pardo A, King TE. PMID: 22679012.
      View in: PubMed   Mentions: 191     Fields:    Translation:HumansCells
    47. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med. 2012 May 24; 366(21):1968-77. Idiopathic Pulmonary Fibrosis Clinical Research Network, Raghu G, Anstrom KJ, King TE, Lasky JA, Martinez FJ. PMID: 22607134; PMCID: PMC3422642.
      View in: PubMed   Mentions: 693     Fields:    Translation:Humans
    48. A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann Intern Med. 2012 May 15; 156(10):684-91. Ley B, Ryerson CJ, Vittinghoff E, Ryu JH, Tomassetti S, Lee JS, Poletti V, Buccioli M, Elicker BM, Jones KD, King TE, Collard HR. PMID: 22586007.
      View in: PubMed   Mentions: 622     Fields:    Translation:Humans
    49. A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2012 Jul 01; 186(1):88-95. Noth I, Anstrom KJ, Calvert SB, de Andrade J, Flaherty KR, Glazer C, Kaner RJ, Olman MA, Idiopathic Pulmonary Fibrosis Clinical Research Network (IPFnet). PMID: 22561965; PMCID: PMC3400994.
      View in: PubMed   Mentions: 176     Fields:    Translation:Humans
    50. Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials. Am J Respir Crit Care Med. 2012 May 15; 185(10):1044-8. Raghu G, Collard HR, Anstrom KJ, Flaherty KR, Fleming TR, King TE, Martinez FJ, Brown KK. PMID: 22505745; PMCID: PMC5448580.
      View in: PubMed   Mentions: 91     Fields:    Translation:Humans
    51. Relative versus absolute change in forced vital capacity in idiopathic pulmonary fibrosis. Thorax. 2012 May; 67(5):407-11. Richeldi L, Ryerson CJ, Lee JS, Wolters PJ, Koth LL, Ley B, Elicker BM, Jones KD, King TE, Ryu JH, Collard HR. PMID: 22426899.
      View in: PubMed   Mentions: 76     Fields:    Translation:Humans
    52. Interstitial lung diseases. Preface. Clin Chest Med. 2012 Mar; 33(1):xiii. King TE, Collard HR, Richeldi L. PMID: 22365255.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    53. Bronchoalveolar lavage pepsin in acute exacerbation of idiopathic pulmonary fibrosis. Eur Respir J. 2012 Feb; 39(2):352-8. Lee JS, Song JW, Wolters PJ, Elicker BM, King TE, Kim DS, Collard HR. PMID: 22183478; PMCID: PMC5529033.
      View in: PubMed   Mentions: 79     Fields:    Translation:Humans
    54. Forced vital capacity in patients with idiopathic pulmonary fibrosis: test properties and minimal clinically important difference. Am J Respir Crit Care Med. 2011 Dec 15; 184(12):1382-9. du Bois RM, Weycker D, Albera C, Bradford WZ, Costabel U, Kartashov A, King TE, Lancaster L, Noble PW, Sahn SA, Thomeer M, Valeyre D, Wells AU. PMID: 21940789.
      View in: PubMed   Mentions: 216     Fields:    Translation:Humans
    55. Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2011 Aug 15; 184(4):459-66. du Bois RM, Weycker D, Albera C, Bradford WZ, Costabel U, Kartashov A, Lancaster L, Noble PW, Raghu G, Sahn SA, Szwarcberg J, Thomeer M, Valeyre D, King TE. PMID: 21616999.
      View in: PubMed   Mentions: 172     Fields:    Translation:Humans
    56. Idiopathic pulmonary fibrosis. Lancet. 2011 Dec 03; 378(9807):1949-61. King TE, Pardo A, Selman M. PMID: 21719092.
      View in: PubMed   Mentions: 1024     Fields:    Translation:Humans
    57. Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2011 Dec 15; 184(12):1390-4. Lee JS, Ryu JH, Elicker BM, Lydell CP, Jones KD, Wolters PJ, King TE, Collard HR. PMID: 21700909; PMCID: PMC3262030.
      View in: PubMed   Mentions: 148     Fields:    Translation:Humans
    58. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. Lancet. 2011 May 21; 377(9779):1760-9. Noble PW, Albera C, Bradford WZ, Costabel U, Glassberg MK, Kardatzke D, King TE, Lancaster L, Sahn SA, Szwarcberg J, Valeyre D, du Bois RM, CAPACITY Study Group. PMID: 21571362.
      View in: PubMed   Mentions: 907     Fields:    Translation:Humans
    59. BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2011 Jul 01; 184(1):92-9. King TE, Brown KK, Raghu G, du Bois RM, Lynch DA, Martinez F, Valeyre D, Leconte I, Morganti A, Roux S, Behr J. PMID: 21474646.
      View in: PubMed   Mentions: 194     Fields:    Translation:Humans
    60. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011 Mar 15; 183(6):788-824. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, Lynch DA, Ryu JH, Swigris JJ, Wells AU, Ancochea J, Bouros D, Carvalho C, Costabel U, Ebina M, Hansell DM, Johkoh T, Kim DS, King TE, Kondoh Y, Myers J, Müller NL, Nicholson AG, Richeldi L, Selman M, Dudden RF, Griss BS, Protzko SL, Schünemann HJ, ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. PMID: 21471066; PMCID: PMC5450933.
      View in: PubMed   Mentions: 3183     Fields:    Translation:Humans
    61. Smoking and subclinical interstitial lung disease. N Engl J Med. 2011 Mar 10; 364(10):968-70. King TE. PMID: 21388315.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    62. Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference. Am J Respir Crit Care Med. 2011 May 01; 183(9):1231-7. du Bois RM, Weycker D, Albera C, Bradford WZ, Costabel U, Kartashov A, Lancaster L, Noble PW, Sahn SA, Szwarcberg J, Thomeer M, Valeyre D, King TE. PMID: 21131468.
      View in: PubMed   Mentions: 178     Fields:    Translation:HumansCTClinical Trials
    63. Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2011 Feb 15; 183(4):431-40. Ley B, Collard HR, King TE. PMID: 20935110.
      View in: PubMed   Mentions: 845     Fields:    Translation:Humans
    64. Workshop on idiopathic pulmonary fibrosis in older adults. Chest. 2010 Sep; 138(3):693-703. Castriotta RJ, Eldadah BA, Foster WM, Halter JB, Hazzard WR, Kiley JP, King TE, Horne FM, Nayfield SG, Reynolds HY, Schmader KE, Toews GB, High KP. PMID: 20822991; PMCID: PMC4694103.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    65. Low prevalence of chronic beryllium disease among workers at a nuclear weapons research and development facility. J Occup Environ Med. 2010 Jun; 52(6):647-52. Arjomandi M, Seward J, Gotway MB, Nishimura S, Fulton GP, Thundiyil J, King TE, Harber P, Balmes JR. PMID: 20523233; PMCID: PMC3313491.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    66. Plasma biomarker profiles in acute exacerbation of idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2010 Jul; 299(1):L3-7. Collard HR, Calfee CS, Wolters PJ, Song JW, Hong SB, Brady S, Ishizaka A, Jones KD, King TE, Matthay MA, Kim DS. PMID: 20418386; PMCID: PMC2904092.
      View in: PubMed   Mentions: 94     Fields:    Translation:Humans
    67. Does chronic microaspiration cause idiopathic pulmonary fibrosis? Am J Med. 2010 Apr; 123(4):304-11. Lee JS, Collard HR, Raghu G, Sweet MP, Hays SR, Campos GM, Golden JA, King TE. PMID: 20362747; PMCID: PMC2851633.
      View in: PubMed   Mentions: 86     Fields:    Translation:HumansAnimals
    68. Undifferentiated connective tissue disease-associated interstitial lung disease: changes in lung function. Lung. 2010 Apr; 188(2):143-9. Kinder BW, Shariat C, Collard HR, Koth LL, Wolters PJ, Golden JA, Panos RJ, King TE. PMID: 20069430; PMCID: PMC2837880.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    69. Clinical decisions. American Board of Internal Medicine maintenance of certification program. N Engl J Med. 2010 Mar 11; 362(10):948-52. Levinson W, King TE, Goldman L, Goroll AH, Kessler B. PMID: 20220192.
      View in: PubMed   Mentions: 13     Fields:    
    70. Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J. 2010 Jun; 35(6):1322-8. Kim EJ, Elicker BM, Maldonado F, Webb WR, Ryu JH, Van Uden JH, Lee JS, King TE, Collard HR. PMID: 19996193.
      View in: PubMed   Mentions: 236     Fields:    Translation:Humans
    71. The 6 minute walk in idiopathic pulmonary fibrosis: longitudinal changes and minimum important difference. Thorax. 2010 Feb; 65(2):173-7. Swigris JJ, Wamboldt FS, Behr J, du Bois RM, King TE, Raghu G, Brown KK. PMID: 19996335; PMCID: PMC3144486.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    72. Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern. Chest. 2009 Nov; 136(5):1397-1405. Kim EJ, Collard HR, King TE. PMID: 19892679; PMCID: PMC2818853.
      View in: PubMed   Mentions: 148     Fields:    Translation:Humans
    73. The SF-36 and SGRQ: validity and first look at minimum important differences in IPF. Respir Med. 2010 Feb; 104(2):296-304. Swigris JJ, Brown KK, Behr J, du Bois RM, King TE, Raghu G, Wamboldt FS. PMID: 19815403; PMCID: PMC2856332.
      View in: PubMed   Mentions: 120     Fields:    Translation:Humans
    74. Multisociety task force recommendations of competencies in Pulmonary and Critical Care Medicine. Am J Respir Crit Care Med. 2009 Aug 15; 180(4):290-5. Buckley JD, Addrizzo-Harris DJ, Clay AS, Curtis JR, Kotloff RM, Lorin SM, Murin S, Sessler CN, Rogers PL, Rosen MJ, Spevetz A, King TE, Malhotra A, Parsons PE. PMID: 19661252.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    75. Quality of life and dyspnoea in patients treated with bosentan for idiopathic pulmonary fibrosis (BUILD-1). Eur Respir J. 2010 Jan; 35(1):118-23. Raghu G, King TE, Behr J, Brown KK, du Bois RM, Leconte I, Roux S, Swigris J. PMID: 19679600; PMCID: PMC2848824.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    76. Fatigue in sarcoidosis: American versus Dutch patients. Sarcoidosis Vasc Diffuse Lung Dis. 2009 Jul; 26(2):92-7. de Kleijn WP, Elfferich MD, De Vries J, Jonker GJ, Lower EE, Baughman RP, King TE, Drent M. PMID: 20560289.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    77. Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial. Lancet. 2009 Jul 18; 374(9685):222-8. King TE, Albera C, Bradford WZ, Costabel U, Hormel P, Lancaster L, Noble PW, Sahn SA, Szwarcberg J, Thomeer M, Valeyre D, du Bois RM, INSPIRE Study Group. PMID: 19570573.
      View in: PubMed   Mentions: 201     Fields:    Translation:Humans
    78. Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosis. Chest. 2009 Jun; 135(6):1557-1563. Kinder BW, Brown KK, McCormack FX, Ix JH, Kervitsky A, Schwarz MI, King TE. PMID: 19255294; PMCID: PMC2716710.
      View in: PubMed   Mentions: 102     Fields:    Translation:Humans
    79. Bosentan for idiopathic pulmonary fibrosis. Curr Opin Investig Drugs. 2008 Nov; 9(11):1171-9. King TE. PMID: 18951296.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    80. Prognostic significance of bronchoalveolar lavage cellular analysis in scleroderma lung disease. Am J Respir Crit Care Med. 2008 Jun 01; 177(11):1292-3; author reply 1293. Kinder BW, King TE. PMID: 18487622.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    81. Idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia should stay separate. Eur Respir J. 2008 May; 31(5):1141-2; author reply 1142-3. Collard HR, King TE. PMID: 18448513.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    82. Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am J Respir Crit Care Med. 2008 Jun 15; 177(12):1338-47. Travis WD, Hunninghake G, King TE, Lynch DA, Colby TV, Galvin JR, Brown KK, Chung MP, Cordier JF, du Bois RM, Flaherty KR, Franks TJ, Hansell DM, Hartman TE, Kazerooni EA, Kim DS, Kitaichi M, Koyama T, Martinez FJ, Nagai S, Midthun DE, Müller NL, Nicholson AG, Raghu G, Selman M, Wells A. PMID: 18388353.
      View in: PubMed   Mentions: 165     Fields:    Translation:Humans
    83. Challenges in pulmonary fibrosis: 8--The need for an international registry for idiopathic pulmonary fibrosis. Thorax. 2008 Mar; 63(3):285-7. Wilson JW, du Bois RM, King TE. PMID: 18308964.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    84. Baseline BAL neutrophilia predicts early mortality in idiopathic pulmonary fibrosis. Chest. 2008 Jan; 133(1):226-32. Kinder BW, Brown KK, Schwarz MI, Ix JH, Kervitsky A, King TE. PMID: 18071016.
      View in: PubMed   Mentions: 135     Fields:    Translation:HumansCells
    85. Challenges in pulmonary fibrosis x 5: the NSIP/UIP debate. Thorax. 2007 Nov; 62(11):1008-12. du Bois R, King TE. PMID: 17965079; PMCID: PMC2117119.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    86. BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2008 Jan 01; 177(1):75-81. King TE, Behr J, Brown KK, du Bois RM, Lancaster L, de Andrade JA, Stähler G, Leconte I, Roux S, Raghu G. PMID: 17901413.
      View in: PubMed   Mentions: 184     Fields:    Translation:Humans
    87. Use of mycophenolate mofetil to treat scleroderma-associated interstitial lung disease. Respir Med. 2008 Jan; 102(1):150-5. Zamora AC, Wolters PJ, Collard HR, Connolly MK, Elicker BM, Webb WR, King TE, Golden JA. PMID: 17822892.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    88. Clinical and genetic risk factors for pneumonia in systemic lupus erythematosus. Arthritis Rheum. 2007 Aug; 56(8):2679-86. Kinder BW, Freemer MM, King TE, Lum RF, Nititham J, Taylor K, Edberg JC, Bridges SL, Criswell LA. PMID: 17665457; PMCID: PMC2875177.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    89. Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2007 Oct 01; 176(7):636-43. Collard HR, Moore BB, Flaherty KR, Brown KK, Kaner RJ, King TE, Lasky JA, Loyd JE, Noth I, Olman MA, Raghu G, Roman J, Ryu JH, Zisman DA, Hunninghake GW, Colby TV, Egan JJ, Hansell DM, Johkoh T, Kaminski N, Kim DS, Kondoh Y, Lynch DA, Müller-Quernheim J, Myers JL, Nicholson AG, Selman M, Toews GB, Wells AU, Martinez FJ, Idiopathic Pulmonary Fibrosis Clinical Research Network Investigators. PMID: 17585107; PMCID: PMC2094133.
      View in: PubMed   Mentions: 435     Fields:    Translation:Humans
    90. Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease? Am J Respir Crit Care Med. 2007 Oct 01; 176(7):691-7. Kinder BW, Collard HR, Koth L, Daikh DI, Wolters PJ, Elicker B, Jones KD, King TE. PMID: 17556720; PMCID: PMC1994238.
      View in: PubMed   Mentions: 112     Fields:    Translation:Humans
    91. Challenges in pulmonary fibrosis. 1: Use of high resolution CT scanning of the lung for the evaluation of patients with idiopathic interstitial pneumonias. Thorax. 2007 Jun; 62(6):546-53. Gotway MB, Freemer MM, King TE. PMID: 17536033; PMCID: PMC2117220.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    92. Accelerated variant of idiopathic pulmonary fibrosis: clinical behavior and gene expression pattern. PLoS One. 2007 May 30; 2(5):e482. Selman M, Carrillo G, Estrada A, Mejia M, Becerril C, Cisneros J, Gaxiola M, Pérez-Padilla R, Navarro C, Richards T, Dauber J, King TE, Pardo A, Kaminski N. PMID: 17534432; PMCID: PMC1868965.
      View in: PubMed   Mentions: 114     Fields:    Translation:HumansCells
    93. Current diagnosis and management of idiopathic pulmonary fibrosis: a survey of academic physicians. Respir Med. 2007 Sep; 101(9):2011-6. Collard HR, Loyd JE, King TE, Lancaster LH. PMID: 17509853; PMCID: PMC2042103.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansPHPublic Health
    94. Respiratory bronchiolitis-interstitial lung disease: long-term outcome. Chest. 2007 Mar; 131(3):664-671. Portnoy J, Veraldi KL, Schwarz MI, Cool CD, Curran-Everett D, Cherniack RM, King TE, Brown KK. PMID: 17356078.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    95. Clinical problem-solving. Anchors away. N Engl J Med. 2007 Feb 01; 356(5):504-9. Calfee CS, Shah SJ, Wolters PJ, Saint S, King TE. PMID: 17267911.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    96. Idiopathic interstitial pneumonia: do community and academic physicians agree on diagnosis? Am J Respir Crit Care Med. 2007 May 15; 175(10):1054-60. Flaherty KR, Andrei AC, King TE, Raghu G, Colby TV, Wells A, Bassily N, Brown K, du Bois R, Flint A, Gay SE, Gross BH, Kazerooni EA, Knapp R, Louvar E, Lynch D, Nicholson AG, Quick J, Thannickal VJ, Travis WD, Vyskocil J, Wadenstorer FA, Wilt J, Toews GB, Murray S, Martinez FJ. PMID: 17255566; PMCID: PMC1899268.
      View in: PubMed   Mentions: 76     Fields:    Translation:Humans
    97. Neurofibromatosis-associated lung disease: a case series and literature review. Eur Respir J. 2007 Jan; 29(1):210-4. Zamora AC, Collard HR, Wolters PJ, Webb WR, King TE. PMID: 16870664.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    98. Anticoagulant therapy and idiopathic pulmonary fibrosis. Chest. 2006 Jul; 130(1):302-3. Kinder BW, Collard HR, King TE. PMID: 16840421.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    99. Current perspectives on the treatment of idiopathic pulmonary fibrosis. Proc Am Thorac Soc. 2006 Jun; 3(4):330-8. Walter N, Collard HR, King TE. PMID: 16738197.
      View in: PubMed   Mentions: 56     Fields:    Translation:Humans
    100. Classification and natural history of the idiopathic interstitial pneumonias. Proc Am Thorac Soc. 2006 Jun; 3(4):285-92. Kim DS, Collard HR, King TE. PMID: 16738191; PMCID: PMC2658683.
      View in: PubMed   Mentions: 172     Fields:    Translation:Humans
    101. Bronchoalveolar lavage fluid D dimer levels are higher and more prevalent in black patients with pulmonary sarcoidosis. Respiration. 2007; 74(3):297-303. Perez RL, Kimani AP, King TE, Aguayo SM, Roman J, Emory Interstitial Lung Disease Center. PMID: 16534178.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    102. Achieving diversity in academic internal medicine: recommendations for leaders. Am J Med. 2006 Jan; 119(1):76-81. Wesson DE, King TE, Todd RF, Torres EA, Hellmann DB, Flack JM, Dubose TD, Schuster VL. PMID: 16431199.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    103. COPD: a dust-induced disease? Chest. 2005 Oct; 128(4):3055-64. Girod CE, King TE. PMID: 16236986.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    104. A critical assessment of treatment options for idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis. 2005 Oct; 22(3):167-74. Shah NR, Noble P, Jackson RM, King TE, Nathan SD, Padilla M, Raghu G, Rhodes MB, Schwarz M, Tino G, Dubois RW. PMID: 16315778; PMCID: PMC1550766.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    105. Association of smoking with dsDNA autoantibody production in systemic lupus erythematosus. Ann Rheum Dis. 2006 May; 65(5):581-4. Freemer MM, King TE, Criswell LA. PMID: 16150789; PMCID: PMC1798144.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    106. Idiopathic interstitial pneumonias: CT features. Radiology. 2005 Jul; 236(1):10-21. Lynch DA, Travis WD, Müller NL, Galvin JR, Hansell DM, Grenier PA, King TE. PMID: 15987960.
      View in: PubMed   Mentions: 74     Fields:    Translation:Humans
    107. The clinical course of patients with idiopathic pulmonary fibrosis. Ann Intern Med. 2005 Jun 21; 142(12 Pt 1):963-7. Martinez FJ, Safrin S, Weycker D, Starko KM, Bradford WZ, King TE, Flaherty KR, Schwartz DA, Noble PW, Raghu G, Brown KK, IPF Study Group. PMID: 15968010.
      View in: PubMed   Mentions: 206     Fields:    Translation:HumansCTClinical Trials
    108. High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. Am J Respir Crit Care Med. 2005 Aug 15; 172(4):488-93. Lynch DA, Godwin JD, Safrin S, Starko KM, Hormel P, Brown KK, Raghu G, King TE, Bradford WZ, Schwartz DA, Richard Webb W, Idiopathic Pulmonary Fibrosis Study Group. PMID: 15894598.
      View in: PubMed   Mentions: 180     Fields:    Translation:HumansCTClinical Trials
    109. Clinical advances in the diagnosis and therapy of the interstitial lung diseases. Am J Respir Crit Care Med. 2005 Aug 01; 172(3):268-79. King TE. PMID: 15879420.
      View in: PubMed   Mentions: 93     Fields:    Translation:Humans
    110. Analyses of efficacy end points in a controlled trial of interferon-gamma1b for idiopathic pulmonary fibrosis. Chest. 2005 Jan; 127(1):171-7. King TE, Safrin S, Starko KM, Brown KK, Noble PW, Raghu G, Schwartz DA. PMID: 15653980.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    111. Inequality in health care: unjust, inhumane, and unattended! Ann Intern Med. 2004 Nov 16; 141(10):815-7. King TE, Wheeler MB. PMID: 15545683.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    112. Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? Am J Respir Crit Care Med. 2004 Oct 15; 170(8):904-10. Flaherty KR, King TE, Raghu G, Lynch JP, Colby TV, Travis WD, Gross BH, Kazerooni EA, Toews GB, Long Q, Murray S, Lama VN, Gay SE, Martinez FJ. PMID: 15256390.
      View in: PubMed   Mentions: 189     Fields:    Translation:Humans
    113. Combined corticosteroid and cyclophosphamide therapy does not alter survival in idiopathic pulmonary fibrosis. Chest. 2004 Jun; 125(6):2169-74. Collard HR, Ryu JH, Douglas WW, Schwarz MI, Curran-Everett D, King TE, Brown KK. PMID: 15189938.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    114. The effect of pulmonary fibrosis on survival in patients with hypersensitivity pneumonitis. Am J Med. 2004 May 15; 116(10):662-8. Vourlekis JS, Schwarz MI, Cherniack RM, Curran-Everett D, Cool CD, Tuder RM, King TE, Brown KK. PMID: 15121492.
      View in: PubMed   Mentions: 80     Fields:    Translation:Humans
    115. The case for diversity in academic internal medicine. Am J Med. 2004 Feb 15; 116(4):284-9. King TE, Dickinson TA, DuBose TD, Flack JM, Hellmann DB, Pamies RJ, Todd RF, Torres EA, Wesson DE. PMID: 14969662.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    116. A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2004 Jan 08; 350(2):125-33. Raghu G, Brown KK, Bradford WZ, Starko K, Noble PW, Schwartz DA, King TE, Idiopathic Pulmonary Fibrosis Study Group. PMID: 14711911.
      View in: PubMed   Mentions: 176     Fields:    Translation:HumansCTClinical Trials
    117. Idiopathic interstitial pneumonias: progress in classification, diagnosis, pathogenesis and management. Trans Am Clin Climatol Assoc. 2004; 115:43-76; discussion 76-8. King TE. PMID: 17060957; PMCID: PMC2263760.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    118. Miscellaneous causes of bronchiolitis: inhalational, infectious, drug-induced, and idiopathic. Semin Respir Crit Care Med. 2003 Oct; 24(5):567-76. King TE. PMID: 16088573.
      View in: PubMed   Mentions: 8     Fields:    
    119. Radiologic findings are strongly associated with a pathologic diagnosis of usual interstitial pneumonia. Chest. 2003 Oct; 124(4):1215-23. Hunninghake GW, Lynch DA, Galvin JR, Gross BH, Müller N, Schwartz DA, King TE, Lynch JP, Hegele R, Waldron J, Colby TV, Hogg JC. PMID: 14555549.
      View in: PubMed   Mentions: 81     Fields:    Translation:Humans
    120. Sarcoidosis following HIV infection: evidence for CD4+ lymphocyte dependence. Chest. 2003 Sep; 124(3):929-35. Morris DG, Jasmer RM, Huang L, Gotway MB, Nishimura S, King TE. PMID: 12970019.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    121. Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2003 Sep 01; 168(5):538-42. Collard HR, King TE, Bartelson BB, Vourlekis JS, Schwarz MI, Brown KK. PMID: 12773325.
      View in: PubMed   Mentions: 259     Fields:    Translation:Humans
    122. Demystifying idiopathic interstitial pneumonia. Arch Intern Med. 2003 Jan 13; 163(1):17-29. Collard HR, King TE. PMID: 12523913.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    123. Basic fibroblast growth factor and its receptors in idiopathic pulmonary fibrosis and lymphangioleiomyomatosis. Am J Respir Crit Care Med. 2002 Sep 01; 166(5):765-73. Inoue Y, King TE, Barker E, Daniloff E, Newman LS. PMID: 12204879.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    124. Future research directions in idiopathic pulmonary fibrosis: summary of a National Heart, Lung, and Blood Institute working group. Am J Respir Crit Care Med. 2002 Jul 15; 166(2):236-46. Crystal RG, Bitterman PB, Mossman B, Schwarz MI, Sheppard D, Almasy L, Chapman HA, Friedman SL, King TE, Leinwand LA, Liotta L, Martin GR, Schwartz DA, Schultz GS, Wagner CR, Musson RA. PMID: 12119236.
      View in: PubMed   Mentions: 68     Fields:    Translation:Humans
    125. Nonspecific interstitial pneumonia and systemic sclerosis. Am J Respir Crit Care Med. 2002 Jun 15; 165(12):1578-9. King TE. PMID: 12070054.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    126. Racial disparities in clinical trials. N Engl J Med. 2002 May 02; 346(18):1400-2. King TE. PMID: 11986416.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    127. Nonspecific interstitial pneumonitis as the sole histologic expression of hypersensitivity pneumonitis. Am J Med. 2002 Apr 15; 112(6):490-3. Vourlekis JS, Schwarz MI, Cool CD, Tuder RM, King TE, Brown KK. PMID: 11959061.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    128. Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis. Eur Respir J. 2002 Mar; 19(3):439-46. Greene KE, King TE, Kuroki Y, Bucher-Bartelson B, Hunninghake GW, Newman LS, Nagae H, Mason RJ. PMID: 11936520.
      View in: PubMed   Mentions: 129     Fields:    Translation:Humans
    129. Respiratory bronchiolitis-associated interstitial lung disease: radiologic features with clinical and pathologic correlation. J Comput Assist Tomogr. 2002 Jan-Feb; 26(1):13-20. Park JS, Brown KK, Tuder RM, Hale VA, King TE, Lynch DA. PMID: 11801899.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    130. The ACCESS study: characterization of sarcoidosis in the United States. Am J Respir Crit Care Med. 2001 Nov 15; 164(10 Pt 1):1754-5. Freemer M, King TE. PMID: 11734416.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    131. Elevation of soluble interleukin-2 receptor levels in the bronchoalveolar lavage from patients with systemic sclerosis. Rheumatol Int. 2001 Nov; 21(3):122-6. Martinez JA, Nishimura C, Guatura SB, Sato E, King TE. PMID: 11765225.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    132. Lung biopsy in patients with usual interstitial pneumonia. Eur Respir J. 2001 Nov; 18(5):895-8. Collard HR, King TE. PMID: 11757643.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    133. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med. 2001 Oct 01; 164(7):1171-81. King TE, Tooze JA, Schwarz MI, Brown KR, Cherniack RM. PMID: 11673205.
      View in: PubMed   Mentions: 285     Fields:    Translation:Humans
    134. Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality. Am J Respir Crit Care Med. 2001 Sep 15; 164(6):1025-32. King TE, Schwarz MI, Brown K, Tooze JA, Colby TV, Waldron JA, Flint A, Thurlbeck W, Cherniack RM. PMID: 11587991.
      View in: PubMed   Mentions: 209     Fields:    Translation:Humans
    135. The clinical significance of histopathologic subgroups in idiopathic interstitial pneumonia: is surgical lung biopsy essential? Semin Respir Crit Care Med. 2001 Aug; 22(4):347-56. Collard HR, King TE. PMID: 16088685.
      View in: PubMed   Mentions: 1     Fields:    
    136. Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2001 Jul 15; 164(2):193-6. Hunninghake GW, Zimmerman MB, Schwartz DA, King TE, Lynch J, Hegele R, Waldron J, Colby T, Müller N, Lynch D, Galvin J, Gross B, Hogg J, Toews G, Helmers R, Cooper JA, Baughman R, Strange C, Millard M. PMID: 11463586.
      View in: PubMed   Mentions: 127     Fields:    Translation:HumansCTClinical Trials
    137. Treatment of idiopathic pulmonary fibrosis: the rise and fall of corticosteroids. Am J Med. 2001 Mar; 110(4):326-8. Collard HR, King TE. PMID: 11239857.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    138. International consensus statement on idiopathic pulmonary fibrosis. Eur Respir J. 2001 Feb; 17(2):163-7. Costabel U, King TE. PMID: 11334114.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    139. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med. 2001 Jan 16; 134(2):136-51. Selman M, King TE, Pardo A. PMID: 11177318.
      View in: PubMed   Mentions: 680     Fields:    Translation:Humans
    140. Acute interstitial pneumonitis. Case series and review of the literature. Medicine (Baltimore). 2000 Nov; 79(6):369-78. Vourlekis JS, Brown KK, Cool CD, Young DA, Cherniack RM, King TE, Schwarz MI. PMID: 11144035.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    141. Interferon gamma-1b for the treatment of idiopathic pulmonary fibrosis. N Engl J Med. 2000 Mar 30; 342(13):974-5. King TE. PMID: 10744491.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    142. Racial disparity in rates of surgery for lung cancer. N Engl J Med. 1999 Oct 14; 341(16):1231-3. King TE, Brunetta P. PMID: 10519904.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    143. A new look at the pathophysiology of asthma. J Natl Med Assoc. 1999 Aug; 91(8 Suppl):9S-15S. King TE. PMID: 12653388; PMCID: PMC2608480.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    144. "Lifeguard lung": endemic granulomatous pneumonitis in an indoor swimming pool. Am J Public Health. 1998 Dec; 88(12):1795-800. Rose CS, Martyny JW, Newman LS, Milton DK, King TE, Beebe JL, McCammon JB, Hoffman RE, Kreiss K. PMID: 9842376; PMCID: PMC1509038.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansPHPublic Health
    145. Update in pulmonary medicine. Ann Intern Med. 1998 Nov 15; 129(10):806-12. King TE. PMID: 9841587.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    146. Morphometric analysis of insulin-like growth factor-I localization in lung tissues of patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1998 Nov; 158(5 Pt 1):1626-35. Uh ST, Inoue Y, King TE, Chan ED, Newman LS, Riches DW. PMID: 9817718.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    147. High expression of neutral endopeptidase in idiopathic diffuse hyperplasia of pulmonary neuroendocrine cells. Am J Respir Crit Care Med. 1998 Nov; 158(5 Pt 1):1593-9. Cohen AJ, King TE, Gilman LB, Magill-Solc C, Miller YE. PMID: 9817713.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    148. Increased expression of the interleukin-10 gene by alveolar macrophages in interstitial lung disease. Am J Physiol. 1997 Sep; 273(3 Pt 1):L676-83. Martinez JA, King TE, Brown K, Jennings CA, Borish L, Mortenson RL, Khan TZ, Bost TW, Riches DW. PMID: 9316504.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    149. Diffuse alveolar hemorrhage with underlying isolated, pauciimmune pulmonary capillaritis. Am J Respir Crit Care Med. 1997 Mar; 155(3):1101-9. Jennings CA, King TE, Tuder R, Cherniack RM, Schwarz MI. PMID: 9116994.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    150. Gold-induced pulmonary disease: clinical features, outcome, and differentiation from rheumatoid lung disease. Am J Respir Crit Care Med. 1997 Mar; 155(3):1011-20. Tomioka R, King TE. PMID: 9116980.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    151. Human mast cell basic fibroblast growth factor in pulmonary fibrotic disorders. Am J Pathol. 1996 Dec; 149(6):2037-54. Inoue Y, King TE, Tinkle SS, Dockstader K, Newman LS. PMID: 8952537; PMCID: PMC1865345.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCells
    152. A lung biopsy is necessary in the management of ANCA-positive patients with chest roentgenographic abnormalities. Sarcoidosis Vasc Diffuse Lung Dis. 1996 Oct; 13(3):238-40. King TE. PMID: 8946591.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    153. Diffuse panbronchiolitis in the United States. Am J Respir Crit Care Med. 1996 Aug; 154(2 Pt 1):497-503. Fitzgerald JE, King TE, Lynch DA, Tuder RM, Schwarz MI. PMID: 8756828.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    154. Lymphangioleiomyomatosis: the pathophysiology of diminished exercise capacity. Am J Respir Crit Care Med. 1996 Apr; 153(4 Pt 1):1368-76. Crausman RS, Jennings CA, Mortenson RL, Ackerson LM, Irvin CG, King TE. PMID: 8616568.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    155. Mast cell-associated basic fibroblast growth factor in the fibrotic response to environmental toxins. The Beryllium Model. Chest. 1996 Mar; 109(3 Suppl):43S-44S. Inoue Y, Cornebise M, Daniloff E, Lloyd J, Tinkle S, King TE, Newman LS. PMID: 8598148.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    156. Pulmonary histiocytosis X: pulmonary function and exercise pathophysiology. Am J Respir Crit Care Med. 1996 Jan; 153(1):426-35. Crausman RS, Jennings CA, Tuder RM, Ackerson LM, Irvin CG, King TE. PMID: 8542154.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    157. Quantitative CT predicts the severity of physiologic dysfunction in patients with lymphangioleiomyomatosis. Chest. 1996 Jan; 109(1):131-7. Crausman RS, Lynch DA, Mortenson RL, King TE, Irvin CG, Hale VA, Newell JD. PMID: 8549175.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    158. How common are renal angiomyolipomas in patients with pulmonary lymphangiomyomatosis? Am J Respir Crit Care Med. 1995 Dec; 152(6 Pt 1):2138-43. Bernstein SM, Newell JD, Adamczyk D, Mortenson RL, King TE, Lynch DA. PMID: 8520787.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    159. Immunohistochemical identification and characterization of smooth muscle-like cells in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1995 Nov; 152(5 Pt 1):1659-65. Ohta K, Mortenson RL, Clark RA, Hirose N, King TE. PMID: 7582311.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    160. Can CT distinguish hypersensitivity pneumonitis from idiopathic pulmonary fibrosis? AJR Am J Roentgenol. 1995 Oct; 165(4):807-11. Lynch DA, Newell JD, Logan PM, King TE, Müller NL. PMID: 7676971.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    161. Surfactant protein A predicts survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1995 Aug; 152(2):751-9. McCormack FX, King TE, Bucher BL, Nielsen L, Mason RJ, McCormac FX. PMID: 7633738.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    162. Human alveolar macrophages produce predominantly the 35-kD pro-forms of interleukin-1 alpha and interleukin-1 beta when stimulated with lipopolysaccharide. Am J Respir Crit Care Med. 1995 May; 151(5):1613-20. Janson RW, Hance KR, King TE. PMID: 7735621.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    163. Correlation of structure and function in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1995 Apr; 151(4):1180-8. Cherniack RM, Colby TV, Flint A, Thurlbeck WM, Waldron JA, Ackerson L, Schwarz MI, King TE. PMID: 7697250.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    164. BOOP: an important cause of migratory pulmonary infiltrates? Eur Respir J. 1995 Feb; 8(2):193-5. King TE. PMID: 7758550.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    165. TCR expression of activated T cell clones in the lungs of patients with pulmonary sarcoidosis. J Immunol. 1994 Nov 01; 153(9):4291-302. Forrester JM, Wang Y, Ricalton N, Fitzgerald JE, Loveless J, Newman LS, King TE, Kotzin BL. PMID: 7930629.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    166. Compartmentalized immune response reflects clinical severity of beryllium disease. Am J Respir Crit Care Med. 1994 Jul; 150(1):135-42. Newman LS, Bobka C, Schumacher B, Daniloff E, Zhen B, Mroz MM, King TE. PMID: 8025739.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    167. Rapidly progressive bronchiolitis obliterans with organizing pneumonia. Am J Respir Crit Care Med. 1994 Jun; 149(6):1670-5. Cohen AJ, King TE, Downey GP. PMID: 8004328.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansAnimalsPHPublic Health
    168. Proliferative and constrictive bronchiolitis: classification and radiologic features. AJR Am J Roentgenol. 1994 Apr; 162(4):803-8. Garg K, Lynch DA, Newell JD, King TE. PMID: 8140994.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    169. Cryptogenic organizing pneumonia: increased expression of interleukin-8 and fibronectin genes by alveolar macrophages. Am J Respir Cell Mol Biol. 1994 Jan; 10(1):100-5. Carré PC, King TE, Mortensen R, Riches DW. PMID: 8292374.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    170. Dyspnea, cough, and interstitial lung disease in a 32-year-old smoker. Chest. 1994 Jan; 105(1):265-7. Wade JF, King TE. PMID: 8275745.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    171. Overview of bronchiolitis. Clin Chest Med. 1993 Dec; 14(4):607-10. King TE. PMID: 8313665.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    172. Respiratory bronchiolitis-associated interstitial lung disease. Clin Chest Med. 1993 Dec; 14(4):693-8. King TE. PMID: 8313673.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    173. Cryptogenic constrictive bronchiolitis. A clinicopathologic study. Am Rev Respir Dis. 1993 Oct; 148(4 Pt 1):1093-101. Kraft M, Mortenson RL, Colby TV, Newman L, Waldron JA, King TE. PMID: 8214931.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    174. Infiltrative and interstitial lung disease in the elderly patient. Clin Chest Med. 1993 Sep; 14(3):501-21. Wade JF, King TE. PMID: 8222566.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    175. Enhanced production of IL-1 receptor antagonist by alveolar macrophages from patients with interstitial lung disease. Am Rev Respir Dis. 1993 Aug; 148(2):495-503. Janson RW, King TE, Hance KR, Arend WP. PMID: 8342915.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    176. Pulmonary capillaritis. The association with progressive irreversible airflow limitation and hyperinflation. Am Rev Respir Dis. 1993 Aug; 148(2):507-11. Schwarz MI, Mortenson RL, Colby TV, Waldron JA, Lynch DA, Hutt MP, Cherniack RM, King TE. PMID: 8102044.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    177. Clonal expansion of lung V delta 1+ T cells in pulmonary sarcoidosis. J Clin Invest. 1993 Jan; 91(1):292-300. Forrester JM, Newman LS, Wang Y, King TE, Kotzin BL. PMID: 8423227; PMCID: PMC330026.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    178. Restrictive lung disease in pregnancy. Clin Chest Med. 1992 Dec; 13(4):607-22. King TE. PMID: 1478021.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    179. Chronic hypersensitivity pneumonitis: use of CT in diagnosis. AJR Am J Roentgenol. 1992 Nov; 159(5):957-60. Buschman DL, Gamsu G, Waldron JA, Klein JS, King TE. PMID: 1414806.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    180. Brief report: idiopathic diffuse hyperplasia of pulmonary neuroendocrine cells and airways disease. N Engl J Med. 1992 Oct 29; 327(18):1285-8. Aguayo SM, Miller YE, Waldron JA, Bogin RM, Sunday ME, Staton GW, Beam WR, King TE. PMID: 1406819.
      View in: PubMed   Mentions: 70     Fields:    Translation:Humans
    181. Idiopathic pulmonary fibrosis. Quantitative assessment of lung pathology. Comparison of a semiquantitative and a morphometric histopathologic scoring system. Am Rev Respir Dis. 1992 Oct; 146(4):1042-7. Hyde DM, King TE, McDermott T, Waldron JA, Colby TV, Thurlbeck WM, Flint WM, Ackerson L, Cherniack RM. PMID: 1416394.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    182. Hypersensitivity pneumonitis: sensitivity of high-resolution CT in a population-based study. AJR Am J Roentgenol. 1992 Sep; 159(3):469-72. Lynch DA, Rose CS, Way D, King TE. PMID: 1503007.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansPHPublic Health
    183. Serum and bronchoalveolar lavage of N-terminal type III procollagen peptides in idiopathic pulmonary fibrosis. Am Rev Respir Dis. 1992 Sep; 146(3):701-6. Low RB, Giancola MS, King TE, Chapitis J, Vacek P, Davis GS. PMID: 1519851.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    184. Cryptogenic organizing pneumonitis. The North American experience. Chest. 1992 Jul; 102(1 Suppl):8S-13S. King TE, Mortenson RL. PMID: 1623812.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    185. Bronchoalveolar lavage in patients with connective tissue disease. J Thorac Imaging. 1992 Jun; 7(3):26-48. King TE, Mortenson RL. PMID: 1501266.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    186. Imaging of pulmonary histiocytosis X. Radiographics. 1992 May; 12(3):515-26. Kulwiec EL, Lynch DA, Aguayo SM, Schwarz MI, King TE. PMID: 1609142.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    187. Urinary levels of bombesin-like peptides in asymptomatic cigarette smokers: a potential risk marker for smoking-related diseases. Cancer Res. 1992 May 01; 52(9 Suppl):2727s-2731s. Aguayo SM, King TE, Kane MA, Sherritt KM, Silvers W, Nett LM, Petty TL, Miller YE. PMID: 1563004.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    188. Increased expression of the interleukin-8 gene by alveolar macrophages in idiopathic pulmonary fibrosis. A potential mechanism for the recruitment and activation of neutrophils in lung fibrosis. J Clin Invest. 1991 Dec; 88(6):1802-10. Carré PC, Mortenson RL, King TE, Noble PW, Sable CL, Riches DW. PMID: 1752942; PMCID: PMC295747.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansCells
    189. The impact of smoking on mechanical properties of the lungs in idiopathic pulmonary fibrosis and sarcoidosis. Am Rev Respir Dis. 1991 Nov; 144(5):1102-6. Hanley ME, King TE, Schwarz MI, Watters LC, Shen AS, Cherniack RM. PMID: 1952439.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    190. Quantitative assessment of lung pathology in idiopathic pulmonary fibrosis. The BAL Cooperative Group Steering Committee. Am Rev Respir Dis. 1991 Oct; 144(4):892-900. Cherniack RM, Colby TV, Flint A, Thurlbeck WM, Waldron J, Ackerson L, King TE. PMID: 1718192.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCTClinical Trials
    191. Role of transferrin, transferrin receptors, and iron in macrophage listericidal activity. J Exp Med. 1991 Aug 01; 174(2):459-66. Alford CE, King TE, Campbell PA. PMID: 1906922; PMCID: PMC2118915.
      View in: PubMed   Mentions: 31     Fields:    Translation:AnimalsCells
    192. Idiopathic pulmonary fibrosis. Abnormalities in the bronchoalveolar lavage content of surfactant protein A. Am Rev Respir Dis. 1991 Jul; 144(1):160-6. McCormack FX, King TE, Voelker DR, Robinson PC, Mason RJ. PMID: 2064123.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    193. Diagnostic advances in idiopathic pulmonary fibrosis. Chest. 1991 Jul; 100(1):238-41. King TE. PMID: 2060352.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    194. Smooth muscle actin is expressed by air space fibroblast-like cells in idiopathic pulmonary fibrosis and hypersensitivity pneumonitis. Chest. 1991 Mar; 99(3 Suppl):47S-48S. Leslie K, King TE, Low R. PMID: 1997270.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    195. Pathogenesis of pulmonary fibrosis in interstitial lung disease. Alveolar macrophage PDGF(B) gene activation and up-regulation by interferon gamma. Am Rev Respir Dis. 1991 Jan; 143(1):167-73. Shaw RJ, Benedict SH, Clark RA, King TE. PMID: 1898843.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    196. Increased pulmonary neuroendocrine cells with bombesin-like immunoreactivity in adult patients with eosinophilic granuloma. J Clin Invest. 1990 Sep; 86(3):838-44. Aguayo SM, King TE, Waldron JA, Sherritt KM, Kane MA, Miller YE. PMID: 2394833; PMCID: PMC296800.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    197. Clinical role of bronchoalveolar lavage in adults with pulmonary disease. Am Rev Respir Dis. 1990 Aug; 142(2):481-6. Goldstein RA, Rohatgi PK, Bergofsky EH, Block ER, Daniele RP, Dantzker DR, Davis GS, Hunninghake GW, King TE, Metzger WJ, et al. PMID: 2200319.
      View in: PubMed   Mentions: 55     Fields:    Translation:Humans
    198. Churg-Strauss pulmonary vasculitis. High-resolution computed tomography scanning and pathologic findings. Am Rev Respir Dis. 1990 Aug; 142(2):458-61. Buschman DL, Waldron JA, King TE. PMID: 2382908.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    199. Pulmonary disease associated with L-tryptophan-induced eosinophilic myalgia syndrome. Clinical and pathologic features. Chest. 1990 May; 97(5):1032-6. Tazelaar HD, Myers JL, Drage CW, King TE, Aguayo S, Colby TV. PMID: 2331898.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    200. Clinical deterioration in patients with idiopathic pulmonary fibrosis: causes and assessment. Am J Med. 1990 Apr; 88(4):396-404. Panos RJ, Mortenson RL, Niccoli SA, King TE. PMID: 2183601.
      View in: PubMed   Mentions: 83     Fields:    Translation:Humans
    201. Collagen cross-linking in adult patients with acute and chronic fibrotic lung disease. Molecular markers for fibrotic collagen. Am Rev Respir Dis. 1990 Feb; 141(2):307-13. Last JA, King TE, Nerlich AG, Reiser KM. PMID: 2301849.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    202. Increased levels of bombesin-like peptides in the lower respiratory tract of asymptomatic cigarette smokers. J Clin Invest. 1989 Oct; 84(4):1105-13. Aguayo SM, Kane MA, King TE, Schwarz MI, Grauer L, Miller YE. PMID: 2794048; PMCID: PMC329766.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimalsCells
    203. Pathologic and immunologic alterations in early stages of beryllium disease. Re-examination of disease definition and natural history. Am Rev Respir Dis. 1989 Jun; 139(6):1479-86. Newman LS, Kreiss K, King TE, Seay S, Campbell PA. PMID: 2729754.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    204. Cavitary lung disease with skin lesions. Chest. 1989 Feb; 95(2):457-8. Leff JA, King TE. PMID: 2914498.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    205. Bronchoalveolar macrophages from patients with idiopathic pulmonary fibrosis are unable to kill facultative intracellular bacteria. Am Rev Respir Dis. 1989 Jan; 139(1):22-7. Savici D, Campbell PA, King TE. PMID: 2492173.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    206. Bronchiolitis obliterans. Lung. 1989; 167(2):69-93. King TE. PMID: 2494394; PMCID: PMC7102245.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    207. Acute eosinophilic pneumonia: a hypersensitivity phenomenon? Am Rev Respir Dis. 1989 Jan; 139(1):249-52. Badesch DB, King TE, Schwarz MI. PMID: 2912347.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    208. Phagocytosis and killing of Listeria monocytogenes by alveolar macrophages: smokers versus nonsmokers. J Infect Dis. 1988 Dec; 158(6):1309-16. King TE, Savici D, Campbell PA. PMID: 3143765.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCells
    209. Gas exchange at a given degree of volume restriction is different in sarcoidosis and idiopathic pulmonary fibrosis. Am J Med. 1988 Aug; 85(2):221-4. Dunn TL, Watters LC, Hendrix C, Cherniack RM, Schwarz MI, King TE. PMID: 3135751.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    210. Quantification of cells recovered by bronchoalveolar lavage. Comparison of cytocentrifuge preparations with the filter method. Am Rev Respir Dis. 1988 Jul; 138(1):74-80. Willcox M, Kervitsky A, Watters LC, King TE. PMID: 3059868.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCells
    211. Idiopathic pulmonary fibrosis. Abnormalities in bronchoalveolar lavage fluid phospholipids. Am Rev Respir Dis. 1988 Mar; 137(3):585-91. Robinson PC, Watters LC, King TE, Mason RJ. PMID: 3345040.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    212. Exacerbation of pulmonary lymphangioleiomyomatosis by exogenous estrogens. Chest. 1987 May; 91(5):782-5. Shen A, Iseman MD, Waldron JA, King TE. PMID: 3032524.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    213. Idiopathic pulmonary fibrosis. Pretreatment bronchoalveolar lavage cellular constituents and their relationships with lung histopathology and clinical response to therapy. Am Rev Respir Dis. 1987 Mar; 135(3):696-704. Watters LC, Schwarz MI, Cherniack RM, Waldron JA, Dunn TL, Stanford RE, King TE. PMID: 3826895.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    214. Bronchoalveolar lavage fluid neutrophils increase after corticosteroid therapy in smokers with idiopathic pulmonary fibrosis. Am Rev Respir Dis. 1986 Jan; 133(1):104-9. Watters LC, King TE, Cherniack RM, Waldron JA, Stanford RE, Willcox ML, Christopher KL, Schwarz MI. PMID: 3942366.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    215. A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis. Am Rev Respir Dis. 1986 Jan; 133(1):97-103. Watters LC, King TE, Schwarz MI, Waldron JA, Stanford RE, Cherniack RM. PMID: 3942381.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    216. Pulmonary cavitation following pulmonary infarction. Medicine (Baltimore). 1985 Sep; 64(5):342-8. Libby LS, King TE, LaForce FM, Schwarz MI. PMID: 4033411.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    217. Waldenström's macroglobulinemia: report of a case with pulmonary involvement and recurrent pneumococcal sepsis after pneumococcal vaccination. J Natl Med Assoc. 1984 Feb; 76(2):184-6, 189. King TE, Schwarz MI, Mathew M. PMID: 6423829; PMCID: PMC2561739.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    218. Lupus pleuritis. Clinical features and pleural fluid characteristics with special reference to pleural fluid antinuclear antibodies. Chest. 1983 Dec; 84(6):714-8. Good JT, King TE, Antony VB, Sahn SA. PMID: 6605838.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    219. The pleuropulmonary manifestations of the postcardiac injury syndrome. Chest. 1983 Oct; 84(4):383-7. Stelzner TJ, King TE, Antony VB, Sahn SA. PMID: 6617272.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    220. Cardiac tamponade complicating the postpericardiotomy syndrome. Chest. 1983 Mar; 83(3):500-3. King TE, Stelzner TJ, Sahn SA. PMID: 6825483.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    221. Multiple pulmonary chondromatous hamartomas. Hum Pathol. 1982 May; 13(5):496-7. King TE, Christopher KL, Schwarz MI. PMID: 7076227.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    222. Bilateral hilar adenopathy: an unusual presentation of renal cell carcinoma. Thorax. 1982 Apr; 37(4):317-8. King TE, Fisher J, Schwarz MI, Patzelt LH. PMID: 7112466; PMCID: PMC459308.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    223. A model of immune complex-mediated pleuropulmonary injury; evidence of deposition of circulating immune complexes in the lung. Am J Pathol. 1980 Jul; 100(1):115-30. Kaplan RL, Schocket AL, King TE, Maulitz RM, Good JT, Stanford RE, Sahn SA. PMID: 6446862; PMCID: PMC1903782.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsPHPublic Health
    224. Circulating immune complexes in pulmonary eosinophilic granuloma. Ann Intern Med. 1979 Sep; 91(3):397-9. King TE, Schwarz MI, Dreisin RE, Pratt DS, Theofilopoulos AN. PMID: 382936.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    Talmadge's Networks
    Concepts (564)
    Derived automatically from this person's publications.
    _
    Co-Authors (39)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _